NCT03918343View on ClinicalTrials.gov

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

September 1, 2024

Study Completion Date

May 23, 2025

Conditions
Hematologic DiseasesStem Cell Transplantation
Interventions
OTHER

Blood sample

blood samples (4 times; 14ml per visit)

Trial Locations (2)

25000

Centre Hospitalier Universitaire de Besançon, Besançon

54 000

Centre Hospitalier Universitaire de Nancy, Nancy

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT03918343 - Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter